Concepedia

Jeffrey A. Stafford

JA

Statistics

Publications

37

Citations

3.4K

H-Index

25

Active since

1988

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

University of Chicago

Takeda (United States)

Io Therapeutics (United States)

Jeffrey A. Stafford is an author at Research Triangle Park Foundation specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1988–2023

37

Publications

37

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

Rakesh Kumar, Victoria B. Knick, Sharon K. Rudolph et al. · Molecular Cancer Therapeutics · 2007 · 517 citations

, , +17

Discovery of Alogliptin:  A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV

Jun Feng, Zhiyuan Zhang, Michael B. Wallace et al. · Journal of Medicinal Chemistry · 2007 · 404 citations · Full text

, , +6

CNS 7056

Gavin J. Kilpatrick, Margaret McIntyre, Richard F. Cox et al. · Anesthesiology · 2007 · 399 citations · Full text

, , +17

Discovery of 5-[[4-[(2,3-Dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor

Philip A. Harris, Amogh Boloor, Mui Cheung et al. · Journal of Medicinal Chemistry · 2008 · 345 citations · Full text

, , +15

Daphniphyllum alkaloids. 14. Total synthesis of (.+-.)-bukittinggine

Clayton H. Heathcock, Jeffrey A. Stafford, David L. Clark · The Journal of Organic Chemistry · 1992 · 139 citations

, , +8

1–5 of 37